Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07103876 · ClinicalTrials.gov registry record
Parathyroidectomy and Mobility Study
A clinical trial of Hyperparathyroidism and Mobility, sponsored by University of Florida.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT07103876 is a study of Hyperparathyroidism and Mobility that is actively recruiting participants, run by University of Florida. The registered enrollment target is 80 participants, below the 123-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07103876, a study of Hyperparathyroidism and Mobility, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether surgical removal of the parathyroid gland (parathyroidectomy) improves physical function and mobility in older adults with primary hyperparathyroidism (PHPT). PHPT, a common endocrine disorder in older adults, is associated with reduced muscle strength, mobility, and quality of life. This prospective observational study will enroll up to 80 participants aged 60 and older undergoing parathyroidectomy at UF Health. Participants will complete physical performance tests, wear an Actigraph device to assess physical activity, and provide blood samples for biomarker analysis at pre- and post-operative time points. The goal is to characterize changes in physical function and activity following surgery and to identify biomarkers that may predict mobility improvements. Findings will help inform future larger-scale studies and could expand surgical indications for PHPT in older adults.
Conditions Studied
Study Locations (1)
Florida
- Clinical and Translational Research Building - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07103876
The ClinicalTrials.gov registry entry for NCT07103876 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 123-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (35% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hyperparathyroidism appearing as the primary indexed condition, and to 0 interventions.
NCT07103876 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07103876 about?
NCT07103876 is a clinical study titled "Parathyroidectomy and Mobility Study". This study evaluates whether surgical removal of the parathyroid gland (parathyroidectomy) improves physical function and mobility in older adults with primary hyperparathyroidism (PHPT). PHPT, a common endocrine disorder in older adults, is associated with reduced muscle strength, mobility, and qua...
What is the current status of trial NCT07103876?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-08-15. Estimated completion is 2027-03-31.
What conditions does trial NCT07103876 study?
This clinical trial studies the following conditions: Hyperparathyroidism, Mobility, Parathyroid.
Who is sponsoring clinical trial NCT07103876?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07103876 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
STP.168 Clinical Study Protocol Parakeet
ACTIVE NOT RECRUITING · NA
-
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
ACTIVE NOT RECRUITING · NA
-
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
COMPLETED · Phase 3
-
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
COMPLETED · Early Phase 1
-
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.